Markets & Economy Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress September 7, 2026 · 5:53 am 1 sources Image: Yahoo Finance ad slot · in-content video 16:9 Coverage More coverageSummit Therapeutics (SMMT) Soars 28% on Ivonescimab ProgressYahoo Finance · September 7, 2026 05:53